Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses "streamlining" the FDA's drug approval process as it relates to the 21st Century Cures Act.
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.
In a 344-77 vote this morning, the U.S. House of Representatives voted overwhelmingly to approve the 21st Century Cures Act.
